Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida

Detalhes bibliográficos
Autor(a) principal: Leite, Caio Abner Vitorino Gonçalves
Data de Publicação: 2014
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
Texto Completo: http://www.repositorio.ufc.br/handle/riufc/15740
Resumo: Hemorrhagic cystitis (HC) induced by ifosfamide (IFO) is an important clinical complication in patients with cancer. Despite prophylaxis, HC is observed. The role of interleukin-1 (IL-1) and tumor necrosis factor (TNF) in the pathogenesis of HC provides targets for treatment. Thus, this study aimed to evaluate the protective effect of the IL-1 receptor antagonist (anakinra) and anti-TNF-alpha antibody (infliximab) in experimental HC-induced by IFO in mice. Swiss , C57BL6 , IL -1R-/-, CASP1-/-, TNFR1-/-, TNFR1/R2-/- mice were used. Animals were submitted to pre- treatment with anakinra 100 mg/ kg, ip or infliximab 5 mg/ Kg, ip, or saline ip, 1h after, they were treated with IFO 400 mg/ kg ip, and 12 h after IFO injection they were killed. Then, it was performed resection of the bladder for macroscopic and histopathological evaluation, vascular permeability assay, myeloperoxidase assay, muscle contractility, cistometrogram and flow cytometry to neutrophils and macrophages. Some animals prior to death, were subjected to evaluation of visceral nociception. Anakinra was able to attenuate hemorrhage, edema, neutrophil infiltration, visceral hypernociception and bladder dysfunction. In addition, it was observed reduction of inflammatory parameters and bladder infiltration of neutrophils and macrophages in IL -1R-/- mice, when compared to wild type animals. In contrast, caspase-1-/- mice did not change the inflammatory pattern when compared to wild type animals. Conversely, infliximab inhibited bladder edema and visceral hypernociception, but did not inhibit hemorrhage, infiltration of neutrophils and macrophages and bladder dysfunction. A reduction in bladder edema was also observed in TNFR1-/- mice, when compared with wild type animals, although TNFR1-/- mice did not block infiltration of neutrophils and macrophages. In other hand, TNFR1/R2-/- mice treated with IFO showed a deterioration of HC. Thus, this study shows the efficacy of anakinra in preventing the HC syndrome induced by IFO, and efficacy of infliximab in inhibiting hypernociception. In addition, the pathogenesis of HC appears to be independent of IL- 1β produced by caspase-1 or IL-1α dependent. Furthermore, HC appears to be partially dependent of TNFR1, but possibly arising from a physiological protection TNFR2.
id UFC-7_d9efdd0426c64f723c6636cd59732824
oai_identifier_str oai:repositorio.ufc.br:riufc/15740
network_acronym_str UFC-7
network_name_str Repositório Institucional da Universidade Federal do Ceará (UFC)
repository_id_str
spelling Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamidaInterleukin-1 receptor blockade with anakinra inhibits ifosfamide induced hemorrhagic cystitisCistiteIfosfamidaProteína Antagonista do Receptor de Interleucina 1InfliximabHemorrhagic cystitis (HC) induced by ifosfamide (IFO) is an important clinical complication in patients with cancer. Despite prophylaxis, HC is observed. The role of interleukin-1 (IL-1) and tumor necrosis factor (TNF) in the pathogenesis of HC provides targets for treatment. Thus, this study aimed to evaluate the protective effect of the IL-1 receptor antagonist (anakinra) and anti-TNF-alpha antibody (infliximab) in experimental HC-induced by IFO in mice. Swiss , C57BL6 , IL -1R-/-, CASP1-/-, TNFR1-/-, TNFR1/R2-/- mice were used. Animals were submitted to pre- treatment with anakinra 100 mg/ kg, ip or infliximab 5 mg/ Kg, ip, or saline ip, 1h after, they were treated with IFO 400 mg/ kg ip, and 12 h after IFO injection they were killed. Then, it was performed resection of the bladder for macroscopic and histopathological evaluation, vascular permeability assay, myeloperoxidase assay, muscle contractility, cistometrogram and flow cytometry to neutrophils and macrophages. Some animals prior to death, were subjected to evaluation of visceral nociception. Anakinra was able to attenuate hemorrhage, edema, neutrophil infiltration, visceral hypernociception and bladder dysfunction. In addition, it was observed reduction of inflammatory parameters and bladder infiltration of neutrophils and macrophages in IL -1R-/- mice, when compared to wild type animals. In contrast, caspase-1-/- mice did not change the inflammatory pattern when compared to wild type animals. Conversely, infliximab inhibited bladder edema and visceral hypernociception, but did not inhibit hemorrhage, infiltration of neutrophils and macrophages and bladder dysfunction. A reduction in bladder edema was also observed in TNFR1-/- mice, when compared with wild type animals, although TNFR1-/- mice did not block infiltration of neutrophils and macrophages. In other hand, TNFR1/R2-/- mice treated with IFO showed a deterioration of HC. Thus, this study shows the efficacy of anakinra in preventing the HC syndrome induced by IFO, and efficacy of infliximab in inhibiting hypernociception. In addition, the pathogenesis of HC appears to be independent of IL- 1β produced by caspase-1 or IL-1α dependent. Furthermore, HC appears to be partially dependent of TNFR1, but possibly arising from a physiological protection TNFR2.Cistite hemorrágica (CH) induzida por ifosfamida (IFO) é uma importante complicação clínica em pacientes com câncer. Atualmente, mesna e hiper- hidratação são utilizadas como profilaxia, a despeito de ainda ser observada CH através de cistoscopia e histopatologia mesmo com essas medidas. A participação de interleucina-1 (IL-1) e fator de necrose tumoral (TNF) na patogênese da CH provê alvos para o tratamento dessa doença. Assim, esse trabalho objetivou avaliar o efeito protetor do antagonista do receptor da IL-1 (anakinra) e do anticorpo anti-TNF- alfa (infliximabe) nas respostas inflamatórias, nociceptivas e funcionais da CH experimental induzida por IFO em camundongos. Foram utilizados camundongos Swiss, C57BL6, IL-1R-/-, CASP1-/-, TNFR1-/-, TNFR1/R2-/-. Os animais WT foram submetidos ao tratamento com anakinra 100 mg/kg i.p. ou infliximabe 5 mg/kgi.p. ou salina i.p., foram tratados 1h após com IFO 400 mg/kg i.p., e 12 h após a IFO foi realizado o sacrifício, com excisão das bexigas para avaliação macroscópica, histopatológica, permeabilidade vascular, mieloperoxidase, contratilidade, cistometrografia e citometria de fluxo para neutrófilos e macrófagos. Alguns animais, antes do sacrifício, foram submetidos a avaliação de nocicepção visceral. Anakinra foi capaz de atenuar hemorragia, edema, infiltrado neutrofílico, hipernocicepção visceral e disfunção vesical. Além disso, foi observada redução dos parâmetros inflamatórios e no infiltrado vesical de neutrófilos e macrófagos em animais IL-1R-/-em comparação a animais selvagens. Por outro lado, com animais caspase-1-/-, não houve mudança no padrão inflamatório. O infliximabe, por sua vez, inibiu o edema vesical e a hipernocicepção visceral, sem interferir na hemorragia, no infiltrado de neutrófilos e macrófagos e na disfunção vesical. Foi observada também uma melhora do edema vesical em animais TNFR1-/-, sem melhora no infiltrado de neutrófilos e macrófagos, e observou-se uma piora da CH em animais TNFR1/R2-/-. Com isso, o presente trabalho demonstra a eficácia de anakinra em prevenir a síndrome da CH induzida por IFO, e a eficácia do infliximabe em inibir a hipernocicepção. Adicionalmente, a patogênese da CH parece ser independente de IL-1β produzido por caspase-1, ou dependente de IL-1α. Além disso, a CH parece ser dependente parcialmente do receptor TNFR1, e possivelmente possui uma proteção fisiológica advinda do receptor TNFR2.Ribeiro, Ronaldo de AlbuquerqueLeite, Caio Abner Vitorino Gonçalves2016-03-28T13:13:10Z2016-03-28T13:13:10Z2014-04-11info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfLEITE, C. A. V. G. Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida. 2014. 117 f. Dissertação (Mestrado em Farmacologia) - Faculdade de Medicina, Universidade Federal do Ceará, 2014.http://www.repositorio.ufc.br/handle/riufc/15740porreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccess2019-10-18T13:12:50Zoai:repositorio.ufc.br:riufc/15740Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2024-09-11T18:41:56.289972Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false
dc.title.none.fl_str_mv Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
Interleukin-1 receptor blockade with anakinra inhibits ifosfamide induced hemorrhagic cystitis
title Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
spellingShingle Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
Leite, Caio Abner Vitorino Gonçalves
Cistite
Ifosfamida
Proteína Antagonista do Receptor de Interleucina 1
Infliximab
title_short Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
title_full Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
title_fullStr Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
title_full_unstemmed Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
title_sort Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida
author Leite, Caio Abner Vitorino Gonçalves
author_facet Leite, Caio Abner Vitorino Gonçalves
author_role author
dc.contributor.none.fl_str_mv Ribeiro, Ronaldo de Albuquerque
dc.contributor.author.fl_str_mv Leite, Caio Abner Vitorino Gonçalves
dc.subject.por.fl_str_mv Cistite
Ifosfamida
Proteína Antagonista do Receptor de Interleucina 1
Infliximab
topic Cistite
Ifosfamida
Proteína Antagonista do Receptor de Interleucina 1
Infliximab
description Hemorrhagic cystitis (HC) induced by ifosfamide (IFO) is an important clinical complication in patients with cancer. Despite prophylaxis, HC is observed. The role of interleukin-1 (IL-1) and tumor necrosis factor (TNF) in the pathogenesis of HC provides targets for treatment. Thus, this study aimed to evaluate the protective effect of the IL-1 receptor antagonist (anakinra) and anti-TNF-alpha antibody (infliximab) in experimental HC-induced by IFO in mice. Swiss , C57BL6 , IL -1R-/-, CASP1-/-, TNFR1-/-, TNFR1/R2-/- mice were used. Animals were submitted to pre- treatment with anakinra 100 mg/ kg, ip or infliximab 5 mg/ Kg, ip, or saline ip, 1h after, they were treated with IFO 400 mg/ kg ip, and 12 h after IFO injection they were killed. Then, it was performed resection of the bladder for macroscopic and histopathological evaluation, vascular permeability assay, myeloperoxidase assay, muscle contractility, cistometrogram and flow cytometry to neutrophils and macrophages. Some animals prior to death, were subjected to evaluation of visceral nociception. Anakinra was able to attenuate hemorrhage, edema, neutrophil infiltration, visceral hypernociception and bladder dysfunction. In addition, it was observed reduction of inflammatory parameters and bladder infiltration of neutrophils and macrophages in IL -1R-/- mice, when compared to wild type animals. In contrast, caspase-1-/- mice did not change the inflammatory pattern when compared to wild type animals. Conversely, infliximab inhibited bladder edema and visceral hypernociception, but did not inhibit hemorrhage, infiltration of neutrophils and macrophages and bladder dysfunction. A reduction in bladder edema was also observed in TNFR1-/- mice, when compared with wild type animals, although TNFR1-/- mice did not block infiltration of neutrophils and macrophages. In other hand, TNFR1/R2-/- mice treated with IFO showed a deterioration of HC. Thus, this study shows the efficacy of anakinra in preventing the HC syndrome induced by IFO, and efficacy of infliximab in inhibiting hypernociception. In addition, the pathogenesis of HC appears to be independent of IL- 1β produced by caspase-1 or IL-1α dependent. Furthermore, HC appears to be partially dependent of TNFR1, but possibly arising from a physiological protection TNFR2.
publishDate 2014
dc.date.none.fl_str_mv 2014-04-11
2016-03-28T13:13:10Z
2016-03-28T13:13:10Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv LEITE, C. A. V. G. Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida. 2014. 117 f. Dissertação (Mestrado em Farmacologia) - Faculdade de Medicina, Universidade Federal do Ceará, 2014.
http://www.repositorio.ufc.br/handle/riufc/15740
identifier_str_mv LEITE, C. A. V. G. Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrágica induzida por ifosfamida. 2014. 117 f. Dissertação (Mestrado em Farmacologia) - Faculdade de Medicina, Universidade Federal do Ceará, 2014.
url http://www.repositorio.ufc.br/handle/riufc/15740
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal do Ceará (UFC)
instname:Universidade Federal do Ceará (UFC)
instacron:UFC
instname_str Universidade Federal do Ceará (UFC)
instacron_str UFC
institution UFC
reponame_str Repositório Institucional da Universidade Federal do Ceará (UFC)
collection Repositório Institucional da Universidade Federal do Ceará (UFC)
repository.name.fl_str_mv Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)
repository.mail.fl_str_mv bu@ufc.br || repositorio@ufc.br
_version_ 1813028911015002112